- Consumer Products
- Latest 4.59
- Currency US$
- Change 0.05
- Percent Change 1.101 %
- Volume 200
- Fri Nov 21, 2014 11:15 AM EST NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Nov 6||$-0.18||Mar 3||$-0.15|
12 months ended Nov 24, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1ß with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.